Skip to main content
OpenTrials

Clinical trial condition

Neurocutaneous Syndromes

Explore clinical trials studying Neurocutaneous Syndromes. Study availability and eligibility vary by location and protocol.

346 public trials 63 recruiting studies
Refine in advanced search Browse all conditions

Neurocutaneous Syndromes trial results

Recruiting

Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders

NCT06081348

Conditions
22Q11 Deletion, 22q11 Deletion Syndrome, ADHD, +59 more
Locations
  • Alberta Children's Hospital - University of Calgary Calgary, Alberta, Canada
  • University of Alberta-Glenrose Edmonton, Alberta, Canada
  • Dalhousie University - IWK Health Centre Halifax, Nova Scotia, Canada
  • McMaster University Hamilton, Ontario, Canada
View Trial Details
Recruiting

Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)

NCT07405164

Conditions
Abnormalities, Multiple, Angiomatosis, Cardiovascular Diseases, +11 more
Locations
  • Beth Israel Deaconess Medical Center ( Site 0107) Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute ( Site 0105) Boston, Massachusetts, United States
  • Karmanos Cancer Center ( Site 0108) Detroit, Michigan, United States
  • Hospital of the University of Pennsylvania Perelman Center for Advanced Medicine ( Site 0100) Philadelphia, Pennsylvania, United States
View all 49 locations
View Trial Details
Recruiting

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

NCT04924075

Conditions
Abnormalities, Multiple, Adenoma, Adenoma, Islet Cell, +31 more
Locations
  • Cedars-Sinai Medical Center ( Site 0110) Los Angeles, California, United States
  • Northwestern University - Robert H. Lurie Comprehensive Cancer Center ( Site 0130) Chicago, Illinois, United States
  • Northwestern Medicine Cancer Center - Warrenville ( Site 0134) Warrenville, Illinois, United States
  • University of Iowa ( Site 0104) Iowa City, Iowa, United States
View all 84 locations
View Trial Details
Recruiting

Clinical and Demographic Characteristics of Adult p Atients With NEurofibromatosis in RUSsia

NCT07088991

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +11 more
Locations
  • Research Site Arkhangelsk, Russia
  • Research Site Chelyabinsk, Russia
  • Research Site Grozny, Russia
  • Research Site Krasnoyarsk, Russia
View all 16 locations
View Trial Details
Recruiting

Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)

NCT02544022

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +17 more
Locations
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Chicago Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details

Related conditions